# FMC share price today (FMC Corporation, FMC)

> FMC Corporation's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. FMC · Materials · Agricultural Inputs · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/fmc

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Getting worse, from the last 12 quarters
- Price: $6.09 (−59.9% in a year)
- P/E: 20.1×, too little history to compare yet
- Revenue (Jun 2026): $867 M (−17.5% on a year ago)
- Profit (Jun 2026): −$186 M (−374.8% on a year ago)
- Operating margin: 11.8% (−3.7 points on a year ago)
- ROE: −107%, FY25
- ROIC: −9.7%, against a 5.3% cost of capital: −15.0 points

The main question: the share price moved −59.9% in a year while yearly earnings per share moved −758.7%. The difference came from the market paying a higher multiple. ## What is the FMC share price today? FMC Corporation's share price was $6.09 at the close on 3 November 2026. That is 50.7% below its average price over the last 200 trading days. In the last 52 weeks it traded between $5 and $18, and at that close it sat 8% of the way up from that low. Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 9 weeks running. Over the last 1 year the share price moved −86% while the S&P 500 moved +21%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 4 September 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does FMC pay? FMC Corporation paid $0.82 per share over the last four reported quarters. The most recent declaration was $0.08 for Jun 2026. At today's price of $6.09 that is a yield of 13.46%, based on dividends already paid, not a forecast. ## Which stock lists is FMC on? FMC is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is FMC profitable? FMC Corporation posted a net loss of $186 M in the Jun 2026 quarter. The full FY25 year was a loss of $2.2 B. That loss is 21.5% of the quarter's revenue. The same quarter a year earlier earned $67.8 M. 8 of the last 12 reported quarters were loss-making. Jun 2026 profit was −$186 M, −374.8% on a year earlier. For the full year, FY25 profit was −$2.2 B (−755.0% on the year before). ## How much revenue does FMC make, and is it growing? FMC Corporation reported $867 M of revenue in the Jun 2026 quarter, −17.5% on the same quarter a year earlier. Over 4 years it has grown −8.9% a year on average. The last full year, FY25, came in at $3.5 B. The last four reported quarters add to $3.3 B. FY25 revenue was $3.5 B, −18.3% on the year before. Recent pace: the last four quarters grew −20.6% on average, against −8.9% a year over the longer run, so this year is growing slower than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew −21.3%, against −10.8% a year over the last 8 quarters (rolling over). ## How much of every $100 of sales does FMC keep? FMC Corporation's operating margin was 11.8% in the Jun 2026 quarter, 3.7 percentage points lower than the same quarter a year ago. Across 5 years it has been between 6.9% and 21.3%. The latest quarter is within that range. Why the margin moved: operating margin changed −3.7 percentage points on the year while gross margin changed +0.8 points. So the drop came mostly from costs below the gross margin, such as staff and overheads, measured against sales. ## Is FMC's profit turning into cash? Over the last 3 years, 36% of FMC Corporation's reported profit came in as cash from its operations, a gap worth watching. In FY25 its operations used $80.2 M of cash, against −$2.2 B of profit. After $96.3 M of spending on assets, free cash was −$177 M: it spent more than its operations brought in. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does FMC's cash go? FMC Corporation does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $298 M on assets over the last 3 years. Averaged over those years that is 2.9% of FY25 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $298 M over the last 3 years. In short: most of the cash goes on covering the loss, not on new assets; spending on assets is small next to it. ## What is FMC's P/E ratio, and how does it compare with its own history? FMC Corporation's P/E is 20.1×, with too little history to compare. Its usual P/E (the middle reading) is 37.1×, over 7 months of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved −758.7% while the price moved −59.9%. The price did better than earnings, which pushed the multiple up within its own range. In short: there is too little history to say whether the multiple is high or low for this company, so the earnings trend underneath matters more than the multiple. ## Is the FMC business getting better or worse? FMC Corporation's business is getting worse. Revenue, profit and EPS growth are shrinking: revenue growth is −21.3% in the latest quarter, against +1.5% at its best in 12 quarters, with ROCE falling at 6.9%. This is based on 12 quarters of 4 measures. Why it matters: falling lines mean any ratio below that looks low should be read with that direction in mind. ## How much does FMC earn on its capital? FMC Corporation earned a ROE of −107% in FY25. Its return on capital used (ROIC) is 15.0 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a −64.5% net margin and 0.36× asset turnover (sales divided by assets). Why the return is what it is (FY25): a −64.5% net margin × 0.36× asset turnover × 4.62× leverage (assets divided by equity) ≈ −107.3% on equity. The margin does its share; borrowing is a big part of it. The key test, return on capital used minus the cost of capital: −9.7% − 5.3% = −15.0 percentage points. The 5.3% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. The −9.7% ROIC above is the latest reading, as reported. The yearly chart below shows FY25 at 3.6%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does FMC have too much debt? FMC Corporation has total debt of $4.4 B against shareholder equity of $1.7 B as of Jun 2026, so its debt is 2.65× its equity. Year by year, that ratio went from 1.06 in FY21 to 2.00 in FY25. Keep that borrowing in mind when reading the returns on this page. ## What is the FMC shareholding pattern? 26.5% of FMC Corporation's tradable shares are in short positions, which are bets that the price will fall, so a large group of traders is betting against it. At normal trading volumes, closing those positions would take about 5.2 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is FMC from balance-sheet trouble? For FMC Corporation, the Z-score is 0.84. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is in the danger zone. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 0.84 is inside the danger zone, so the balance sheet is a real risk. ## How does FMC rank in its industry? 24.0 out of 100, rank 10 of 11 in Agricultural Inputs, with 75% of the evidence available. FMC Corporation scores 24.0 out of 100 against the 11 companies it is compared with in Agricultural Inputs, ranking 10. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 4.3 + 6.2 + 8.8 + 4.7 = 24. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is FMC compared with? FMC ranks 10 of 11 Agricultural Inputs companies on the 4-Factor Sector Score, with 24.0 out of 100. 1. [CF Industries Holdings, Inc.](https://www.sectoralpha.in/us/stocks/cf) CF · turning · Sector-leading setup · 85% evidence 86.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 31.4/35 · Revenue 20% · Profit 61.2% · Operating margin change 15.3 points · 95% evidence Capital efficiency 20.4/25 · ROCE 20.8% · Operating margin 49.3% · 76% evidence Valuation 15.9/20 · P/E 7.9× · PEG 0.24 · 65% evidence Relative strength 18.7/20 · Lead over its industry 38.7% · Lead over S&P 500 1.8% · 1 year 42.4% · 100% evidence · 4 of 12 weeks ahead Exact sum: 31.4 + 20.4 + 15.9 + 18.7 = 86.4 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 2. [CVR Partners, LP](https://www.sectoralpha.in/us/stocks/uan) UAN · quiet · Sector-leading setup · 85% evidence 82.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 32.2/35 · Revenue 17.3% · Profit 83% · Operating margin change 14.8 points · 95% evidence Capital efficiency 18.8/25 · ROCE 20.2% · Operating margin 42.4% · 76% evidence Valuation 16.2/20 · P/E 7.4× · PEG 0.06 · 65% evidence Relative strength 15.4/20 · Lead over its industry 31% · Lead over S&P 500 -3.7% · 1 year 19% · 100% evidence · 5 of 12 weeks ahead Exact sum: 32.2 + 18.8 + 16.2 + 15.4 = 82.6 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 3. [Nutrien Ltd.](https://www.sectoralpha.in/us/stocks/ntr) NTR · turning · Most evidence points up · 75% evidence 65.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.1/35 · Revenue 9.1% · Profit 73.3% · Operating margin change -0.3 points · 95% evidence Capital efficiency 14.5/25 · ROCE 8.7% · Operating margin 17.5% · 76% evidence Valuation 10.3/20 · P/E 12.7× · PEG n/a · 15% evidence Relative strength 15.6/20 · Lead over its industry 30.3% · Lead over S&P 500 -4.4% · 1 year 21.9% · 100% evidence · 6 of 12 weeks ahead Exact sum: 25.1 + 14.5 + 10.3 + 15.6 = 65.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [The Scotts Miracle-Gro Company](https://www.sectoralpha.in/us/stocks/smg) SMG · turning · Evidence leans up · 85% evidence 63.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.1/35 · Revenue 1.3% · Profit 39.6% · Operating margin change -2.4 points · 95% evidence Capital efficiency 17.4/25 · ROCE 22.8% · Operating margin 16.8% · 76% evidence Valuation 11.2/20 · P/E 55× · PEG 1.15 · 65% evidence Relative strength 16.8/20 · Lead over its industry 31.1% · Lead over S&P 500 -4% · 1 year 9.4% · 100% evidence · 0 of 12 weeks ahead Exact sum: 18.1 + 17.4 + 11.2 + 16.8 = 63.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [ICL Group Ltd](https://www.sectoralpha.in/us/stocks/icl) ICL · quiet · Evidence leans up · 85% evidence 58.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.5/35 · Revenue 10.9% · Profit -16.9% · Operating margin change 2.6 points · 95% evidence Capital efficiency 11.9/25 · ROCE 8.1% · Operating margin 12.5% · 76% evidence Valuation 14.7/20 · P/E 21.1× · PEG 0.11 · 65% evidence Relative strength 11.4/20 · Lead over its industry 5.7% · Lead over S&P 500 -22.5% · 1 year -22.7% · 100% evidence · 0 of 12 weeks ahead Exact sum: 20.5 + 11.9 + 14.7 + 11.4 = 58.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Intrepid Potash, Inc.](https://www.sectoralpha.in/us/stocks/ipi) IPI · quiet · Evidence leans down · 67% evidence 46.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 17.3/35 · Revenue 7.8% · Profit n/a · Operating margin change -0.8 points · 71% evidence Capital efficiency 7.1/25 · ROCE 2.9% · Operating margin 2.5% · 76% evidence Valuation 10.0/20 · P/E 16.4× · PEG n/a · 15% evidence Relative strength 11.9/20 · Lead over its industry 15.8% · Lead over S&P 500 -15.7% · 1 year 22% · 100% evidence · 3 of 12 weeks ahead Exact sum: 17.3 + 7.1 + 10 + 11.9 = 46.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [Del Monte Corporation](https://www.sectoralpha.in/us/stocks/dmc) DMC · quiet · Evidence leans down · 75% evidence 40.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 11.2/35 · Revenue -0.2% · Profit -77.3% · Operating margin change -1.8 points · 95% evidence Capital efficiency 9.2/25 · ROCE 5.6% · Operating margin 3.9% · 76% evidence Valuation 9.4/20 · P/E 40.9× · PEG n/a · 15% evidence Relative strength 10.8/20 · Lead over its industry 2.3% · Lead over S&P 500 -25.6% · 1 year -27.2% · 100% evidence · 1 of 12 weeks ahead Exact sum: 11.2 + 9.2 + 9.4 + 10.8 = 40.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [The Mosaic Company](https://www.sectoralpha.in/us/stocks/mos) MOS · quiet · Evidence leans down · 75% evidence 35.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 9.8/35 · Revenue 8.8% · Profit -168.1% · Operating margin change -8.2 points · 95% evidence Capital efficiency 6.6/25 · ROCE 2.5% · Operating margin -0.1% · 76% evidence Valuation 10.6/20 · P/E 9× · PEG n/a · 15% evidence Relative strength 8.5/20 · Lead over its industry 0.3% · Lead over S&P 500 -27% · 1 year -28% · 100% evidence · 3 of 12 weeks ahead Exact sum: 9.8 + 6.6 + 10.6 + 8.5 = 35.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Corteva, Inc.](https://www.sectoralpha.in/us/stocks/ctva) CTVA · basing · Most evidence points down · 75% evidence 33.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 11.8/35 · Revenue -40.3% · Profit -132.5% · Operating margin change -14.4 points · 95% evidence Capital efficiency 12.3/25 · ROCE 11.6% · Operating margin 12.8% · 76% evidence Valuation 9.1/20 · P/E 41.9× · PEG n/a · 15% evidence Relative strength 0.0/20 · Lead over its industry -77.3% · Lead over S&P 500 -83.9% · 1 year -81.5% · 100% evidence · 3 of 12 weeks ahead Exact sum: 11.8 + 12.3 + 9.1 + 0 = 33.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. FMC Corporation this page FMC · quiet · Most evidence points down · 75% evidence 24.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 4.3/35 · Revenue -21.3% · Profit -2802.9% · Operating margin change -3.7 points · 95% evidence Capital efficiency 6.2/25 · ROCE 1.5% · Operating margin 11.8% · 76% evidence Valuation 8.8/20 · P/E 52.7× · PEG n/a · 15% evidence Relative strength 4.7/20 · Lead over its industry -36.3% · Lead over S&P 500 -54.3% · 1 year -56.5% · 100% evidence · 1 of 12 weeks ahead Exact sum: 4.3 + 6.2 + 8.8 + 4.7 = 24 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [Glass House Brands Inc.](https://www.sectoralpha.in/us/stocks/glas) GLAS · quiet · Most evidence points down · 75% evidence 17.7 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Jun 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Agricultural Inputs](https://www.sectoralpha.in/us/sectors/agricultural-inputs), all 11 compared on one page. ## Which companies are close to FMC in size? FMC is the 9th largest of 11 Agricultural Inputs companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: ICL Group, The Scotts Miracle-Gro Company, Del Monte Corporation and CVR Partners, LP. Just below it: Intrepid Potash, Inc. and Glass House Brands Inc. ### Agricultural Inputs companies close in size

1. [ICL Group Ltd](https://www.sectoralpha.in/us/stocks/icl) $5.6 billion
2. [The Scotts Miracle-Gro Company](https://www.sectoralpha.in/us/stocks/smg) $3.6 billion
3. [Del Monte Corporation](https://www.sectoralpha.in/us/stocks/dmc) $1.3 billion
4. [CVR Partners, LP](https://www.sectoralpha.in/us/stocks/uan) $1.3 billion
5. FMC Corporation $947 million
6. [Intrepid Potash, Inc.](https://www.sectoralpha.in/us/stocks/ipi) $407 million
7. [Glass House Brands Inc.](https://www.sectoralpha.in/us/stocks/glas) $221 million

[All 11 Agricultural Inputs companies, largest first](https://www.sectoralpha.in/us/sectors/agricultural-inputs#all-companies)

### Companies close in size in other industries

1. [IRADIMED CORPORATION](https://www.sectoralpha.in/us/stocks/irmd) $1 billion · Medical Devices
2. [Universal Corporation](https://www.sectoralpha.in/us/stocks/uvv) $1 billion · Tobacco
3. FMC Corporation $1 billion
4. [Sabine Royalty Trust](https://www.sectoralpha.in/us/stocks/sbr) $1 billion · Oil & Gas Midstream
5. [Oil-Dri Corporation of America](https://www.sectoralpha.in/us/stocks/odc) $1 billion · Specialty Chemicals

## What else do people ask about FMC? ### What were FMC's latest quarterly results? FMC Corporation reported revenue of $867 M and a net loss of $186 M for the Jun 2026 quarter. Revenue fell 17.5% and profit fell 374.8% compared with a year earlier. Earnings per share were −$1.49. The operating margin was 11.8%, 3.7 percentage points lower than a year earlier (as of 3 November 2026). ### What is FMC's market cap? FMC Corporation's market capitalisation is $947 M at a stock price of $6.09. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is FMC performing? FMC Corporation's latest readings are below. In its latest quarter, revenue fell 17.5% and profit fell 374.8% compared with a year earlier. Over the past 13 weeks it has done worse than the S&P 500, for 9 weeks running. This describes what the data did, not a rating (as of 3 November 2026). ### Will FMC's stock price go up? This page does not forecast FMC Corporation's stock price. What it shows instead: the stock price is $6.09. Nobody can reliably say which way a price will move, and this site does not try (as of 3 November 2026). ### Does FMC have too much debt? Yes, FMC Corporation has a lot of debt: its debt is 452.24× its equity. A year-by-year history of its borrowings is not in our data, so this uses the latest reading. Keep that borrowing in mind when reading the returns on this page (as of 3 November 2026). ### Where is FMC in its business cycle? FMC Corporation's FY25 operating margin was 6.9%, against a 5-year range of 6.9% to 21.3%: the low end of its own range, which is often where recoveries start. The latest quarter was 11.8%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the FMC story? The main question: the share price moved −59.9% in a year while yearly earnings per share moved −758.7%. The difference came from the market paying a higher multiple. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is FMC a stock worth studying right now? What the numbers show: FMC Corporation's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: whether earnings grow into a price that has already moved. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.